|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:available_on
|
gptkb:tablet
Injection
|
|
gptkbp:brand
|
gptkb:Protonix
|
|
gptkbp:category
|
Category B
|
|
gptkbp:class
|
Proton pump inhibitor
|
|
gptkbp:clinical_trial
|
Phase IV
Phase III
|
|
gptkbp:contraindication
|
Severe liver disease
Hypersensitivity to pantoprazole
|
|
gptkbp:counseling_services
|
Do not crush or chew
Monitor magnesium levels during long-term use
Report severe diarrhea
Take before meals
|
|
gptkbp:dosage_form
|
Injectable solution
Delayed-release tablet
|
|
gptkbp:duration
|
24 hours
|
|
gptkbp:excretion
|
Urine
|
|
gptkbp:formulation
|
Enteric-coated
|
|
gptkbp:healthcare
|
gptkb:2000
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Protonix
|
|
gptkbp:indication
|
Short-term treatment of GERD
Long-term treatment of Zollinger-Ellison syndrome
|
|
gptkbp:ingredients
|
gptkb:Pantoprazole
|
|
gptkbp:interacts_with
|
gptkb:Clopidogrel
gptkb:Methotrexate
gptkb:Digoxin
gptkb:Warfarin
|
|
gptkbp:invention
|
gptkb:2011
|
|
gptkbp:lifespan
|
1 hour
|
|
gptkbp:manufacturer
|
gptkb:Takeda_Pharmaceuticals
|
|
gptkbp:marketed_as
|
gptkb:Protonix
|
|
gptkbp:metabolism
|
Liver
|
|
gptkbp:premiered_on
|
1 hour
|
|
gptkbp:previous_name
|
gptkb:Yes
|
|
gptkbp:route_of_administration
|
Intravenous
Oral
|
|
gptkbp:side_effect
|
gptkb:Nausea
gptkb:Clostridium_difficile_infection
Diarrhea
Kidney disease
Vomiting
Headache
Abdominal pain
Bone fractures
Low magnesium levels
|
|
gptkbp:storage
|
Room temperature
Protect from light
|
|
gptkbp:used_for
|
gptkb:Zollinger-Ellison_syndrome
Gastroesophageal reflux disease (GERD)
Erosive esophagitis
|
|
gptkbp:bfsParent
|
gptkb:pantoprazole
|
|
gptkbp:bfsLayer
|
6
|